Risk assessment of clinically significant portal hypertension by means of hepatosplenic volumetry in compensated cirrhosis

被引：0
|
作者：
Romero Cristobal, Mario [1 ]
Clemente, Ana [1 ]
Ramon Botella, Enrique [2 ]
Ortega, Olga [1 ]
Velilla, Elena [1 ]
Matilla, Ana M. [1 ,3 ]
Marquez, Laura [1 ]
Magdalena Salcedo, Maria [1 ,3 ,4 ]
Alonso, Sonia [1 ]
Vega Catalina, Maria [1 ]
Fernandez, Ainhoa [1 ]
Diaz Fontela, Fernando [1 ]
Ibanez, Luis [1 ]
Rincon, Diego [1 ,3 ]
Banares, Rafael [1 ,3 ,4 ]
机构：
[1] Hosp Gregorio Maranon, Hepatol, Madrid, Spain
[2] Hosp Gregorio Maranon, Radiol, Madrid, Spain
[3] Ciberehd, Madrid, Spain
[4] Univ Complutense, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT178
引用
收藏
页码：S742 / S742
页数：1
相关论文
共 50 条
  • [21] ASSESSMENT OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION AMONG PERIPORTAL FIBROSIS VERSUS LIVER CIRRHOSIS PATIENTS USING FIBROSCAN
    Allam, Dalia
    Abdalla, Hala
    GUT, 2022, 71 : A69 - A69
  • [22] Noninvasive Prediction of Clinically Significant Portal Hypertension and Esophageal Varices in Patients With Compensated Liver Cirrhosis (vol 103, pg 1159, 2008)
    Berzigotti, Annalisa
    Gilabert, Rosa
    Abraldes, Juan G.
    Nicolau, Carlos
    Bru, Concepcio
    Bosch, Jaime
    Garcia-Pagan, Juan C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (07): : 1141 - 1141
  • [23] Simple blood tests to diagnose compensated advanced chronic liver disease and stratify risk of clinically significant portal hypertension
    Semmler, Georg
    Hartl, Lukas
    Mendoza, Yuly Paulin
    Simbrunner, Benedikt
    Jachs, Mathias
    Balcar, Lorenz
    Schwarz, Michael
    Hofer, Benedikt Silvester
    Fritz, Laurenz
    Schedlbauer, Anna
    Stopfer, Katharina
    Neumayer, Daniela
    Maurer, Jurij
    Szymanski, Robin
    Meyer, Elias Laurin
    Scheiner, Bernhard
    Quehenberger, Peter
    Trauner, Michael
    Aigner, Elmar
    Berzigotti, Annalisa
    Reiberger, Thomas
    Mandorfer, Mattias
    HEPATOLOGY, 2024, 80 (04) : 791 - 806
  • [24] NON-INVASIVE ASSESSMENT AND PREDICTION OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
    Rye, K.
    Mortimore, G.
    Austin, A.
    Freeman, J.
    GUT, 2011, 60
  • [25] Von Willebrand factor predicts clinically significant portal hypertension in patients with liver cirrhosis
    Homoncik, M.
    Ferlitsch, A.
    Reiberger, T.
    Ulbrich, G.
    Gangl, A.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S114 - S115
  • [26] INFLAMMATION BIOMARKERS REFLECT DISEASE SEVERITY AND DISCRIMINATE CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN CIRRHOSIS
    Skovgaard, Emilie
    Kimer, Nina
    Busk, Troels Malte
    Karsdal, Morten
    Leeming, Diana J.
    Moller, Soren
    HEPATOLOGY, 2023, 78 : S1427 - S1428
  • [27] EUS Assessment of Portal Pressure Gradient Identifies a Significant Amount of Previously Undiagnosed Clinically Significant Portal Hypertension
    Edelson, Jerome C.
    Edelson, Scott
    Rockey, Don
    Horn, Christian
    Magulick, John
    Quiles, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S849 - S850
  • [28] Liver Stiffness Measured By Vibration Controlled Transient Elastography Is An Excellent Surrogate for Identifying Clinically Significant Portal Hypertension In Patients With Compensated NASH Cirrhosis
    Vuppalanchi, Raj
    Lawitz, Eric
    Abdelmalek, Manal F.
    Rinella, Mary E.
    Harrison, Stephen A.
    Ryan, Michael J.
    Traber, Peter G.
    Garcia-Tsao, Guadalupe
    Chalasani, Naga P.
    HEPATOLOGY, 2017, 66 : 245A - 245A
  • [29] Sequential algorithm of spleen stiffness measured by a dedicated 100 Hz examination and Baveno VII criteria for clinically significant portal hypertension in compensated cirrhosis
    He, Ruiling
    Liu, Chuan
    Jie, Li
    Ma, Jianzhong
    Guo, Ying
    Guo, Xiaoqing
    Liu, Shirong
    Gao, Bo
    Liu, Ning
    Chen, Mingkai
    Zhou, Hongwei
    Tang, Tianyu
    Shi, Yu
    Ju, Shenghong
    Yan Huadong
    Qi, Xiaolong
    JOURNAL OF HEPATOLOGY, 2022, 77 : S636 - S636
  • [30] Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis
    Lemoine, M.
    Katsahian, S.
    Ziol, M.
    Nahon, P.
    Ganne-Carrie, N.
    Kazemi, F.
    Grando-Lemaire, V.
    Trinchet, J. -C.
    Beaugrand, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (09) : 1102 - 1110
12345